Dessislava Marinova

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbués, Jesús Gonzalo‐Asensio, Dessislava Marinova et al. · Vaccine · 2013 · 258 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial

François Spertini, R Audran, Reza Chakour et al. · The Lancet Respiratory Medicine · 2015 · 175 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

ESX-1-induced apoptosis is involved in cell-to-cell spread of<i>Mycobacterium tuberculosis</i>

Henar Alonso, Santiago Uranga, Dessislava Marinova et al. · Cellular Microbiology · 2013 · 143 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17–Dependent Mechanism

Nacho Aguiló, Samuel Álvarez-Arguedas, Santiago Uranga et al. · The Journal of Infectious Diseases · 2015 · 136 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17